A novel mouse model for obesity, type 2 diabetes, and nonalcoholic fatty liver disease

被引:0
|
作者
Dhar, M
Sommardahl, C
Castellani, L
Johnson, D
机构
来源
OBESITY RESEARCH | 2003年 / 11卷
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:A5 / A5
页数:1
相关论文
共 50 条
  • [21] Obesity and Nonalcoholic Fatty Liver Disease
    Chaney, Amanda
    NURSING CLINICS OF NORTH AMERICA, 2021, 56 (04) : 543 - 552
  • [22] Nonalcoholic fatty liver disease of obesity
    Sachdev, Mankanwal S.
    Riely, Caroline A.
    Madan, Atul K.
    OBESITY SURGERY, 2006, 16 (11) : 1412 - 1419
  • [23] Nonalcoholic Fatty Liver Disease of Obesity
    Mankanwal S Sachdev
    Caroline A Riely
    Atul K Madan
    Obesity Surgery, 2006, 16 : 1412 - 1419
  • [24] Obesity and nonalcoholic fatty liver disease
    Angulo, Paul
    NUTRITION REVIEWS, 2007, 65 (06) : S57 - S63
  • [25] High prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in type 2 diabetes mellitus
    Thiruppathi, Shankar
    Falck-Ytter, Yngve
    Dasarathy, Srinivasan
    Rogers, Nicholette
    McCullough, Arthur J.
    HEPATOLOGY, 2006, 44 (04) : 660A - 660A
  • [26] Nonalcoholic Fatty Liver Disease: A Novel Cardiometabolic Risk Factor for Type 2 Diabetes and Its Complications
    Targher, Giovanni
    Byrne, Christopher D.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (02): : 483 - 495
  • [27] Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes and Chronic Kidney Disease
    Adrian, Therese
    Hornum, Mads
    Knop, Filip Krag
    Almdal, Thomas
    Rossing, Peter
    Lida, Lisa
    Heinrich, Niels Sondergaard
    Boer, Vincent Oltman
    Marsman, Anouk
    Petersen, Esben Thade
    Siebner, Hartwig Roman
    Feldt-Rasmussen, Bo
    NEPHRON, 2023, 147 (06) : 317 - 328
  • [28] Statins, diabetes, obesity, nonalcoholic fatty liver disease, and hepatocellular carcinoma
    Jun Han
    Wen-Tao Yan
    Bing Quan
    Ming-Da Wang
    Tian Yang
    Hepatobiliary & Pancreatic Diseases International, 2019, 18 (02) : 202 - 202
  • [29] Circulating Thrombospondin-2 as a Novel Fibrosis Biomarker of Nonalcoholic Fatty Liver Disease in Type 2 Diabetes
    Lee, Chi-Ho
    Seto, Wai-Kay
    Lui, David Tak-Wai
    Fong, Carol Ho-Yi
    Wan, Helen Yilin
    Cheung, Chloe Yu-Yan
    Chow, Wing-Sun
    Woo, Yu-Cho
    Yuen, Man-Fung
    Xu, Aimin
    Lam, Karen Siu-Ling
    DIABETES CARE, 2021, 44 (09) : 2089 - 2097
  • [30] Statins, diabetes, obesity, nonalcoholic fatty liver disease, and hepatocellular carcinoma
    Han, Jun
    Yan, Wen-Tao
    Quan, Bing
    Wang, Ming-Da
    Yang, Tian
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2019, 18 (02) : 202 - 202